imal reports suggest that reflex activation of cardiac sympathetic nerves can evoke coronary vasoconstriction. Conversely, physiological stress may induce coronary vasodilation to meet an increased metabolic demand. Whether the sympathetic nervous system can modulate coronary vasomotor tone in response to stress in humans is unclear. Coronary blood velocity (CBV), an index of coronary blood flow, can be measured in humans by noninvasive duplex ultrasound. We studied 11 healthy volunteers and measured beat-by-beat changes in CBV, blood pressure, and heart rate during 1) static handgrip for 20 s at 10% and 70% of maximal voluntary contraction; 2) lower body negative pressure at Ϫ10 and Ϫ30 mmHg for 3 min each; 3) cold pressor test for 90 s; and 4) hypoxia (10% O2), hyperoxia (100% O2), and hypercapnia (5% CO2) for 5 min each. At the higher level of handgrip, mean blood pressure increased (P Ͻ 0.001), whereas CBV did not change [P ϭ not significant (NS)]. In addition, during lower body negative pressure, CBV decreased (P Ͻ 0.02; and P Ͻ 0.01, for Ϫ10 and Ϫ30 mmHg, respectively), whereas blood pressure did not change (P ϭ NS). The dissociation between the responses of CBV and blood pressure to handgrip and lower body negative pressure is consistent with coronary vasoconstriction. During hypoxia, CBV increased (P Ͻ 0.02) and decreased during hyperoxia (P Ͻ 0.01), although blood pressure did not change (P ϭ NS), suggesting coronary vasodilation during hypoxia and vasoconstriction during hyperoxia. In contrast, concordant increases in CBV and blood pressure were noted during the cold pressor test, and hypercapnia had no effects on either parameter. Thus the physiological stress known to be associated with sympathetic activation can produce coronary vasoconstriction in humans. Contrasting responses were noted during systemic hypoxia and hyperoxia where mechanisms independent of autonomic influences appear to dominate the vascular end-organ effects.
UNTIL RECENTLY, the assessment of coronary vascular responses to physiological stress was largely confined to animal models. However, advances in ultrasound technology now enable investigators to assess coronary blood flow velocity in humans during physiological (60) and pharmacological interventions noninvasively (7, 23, 38) . Given its excellent time resolution, this technique permits the assessment of beat-by-beat changes of coronary blood flow. Employing this methodology, we recently measured coronary blood flow velocity in response to static handgrip in the left internal mammary artery (LIMA) graft to the anterior descending branch of the left coronary artery in patients who had undergone coronary bypass grafting (40) . In line with previous animal reports (1, 24) , we found that static handgrip exercise was associated with coronary vasoconstriction in humans (40) . Furthermore, these studies demonstrated an onset of vasoconstriction within 15 s of handgrip.
In this report, we used duplex ultrasound technology to determine the coronary vascular responses to a series of physiological stressors encountered by humans. Since in patients with heart disease, myocardial ischemia or left ventricular dysfunction are often provoked by physiological stress, we believe that understanding the coronary vascular responses to stress is of paramount importance.
In view of the mounting evidence that the sympathetic adrenergic system is capable of modulating coronary vasomotor tone (32, 56) , we examined the responses of coronary blood velocity (CBV), a surrogate of coronary blood flow, to physiological interventions in conscious humans. The studies were performed on two separate days. On day 1, subjects underwent short bouts of graded handgrip exercise, lower body negative pressure (LBNP, simulates orthostasis), and a cold pressor test (CPT; a nonspecific sympathetic stimulus). On day 2, coronary vascular resistance responses were evaluated during exposure to hypoxia (10% O 2 ), hyperoxia (100% O 2 ), and hypercapnia (5% CO 2 ).
We hypothesized that sympathetic activation can increase coronary vasoconstrictor tone and that this will be most apparent when metabolic coronary vasodilator mechanisms are not significantly engaged. Our findings suggest that coronary vasoconstriction occurs in humans during short bouts of highintensity static handgrip as well as during LBNP and are consistent with increased sympathetic drive targeted to the coronary vasculature. Coronary vasoconstriction also occurs when arterial O 2 tension is high at rest, whereas coronary vasodilation occurs during hypoxia, suggesting that an altered O 2 availability is capable of modulating coronary vascular tone via nonneural mechanisms.
METHODS

Study Population
Eleven healthy normotensive volunteers (8 men and 3 women: age 27 Ϯ 1 yr, and body mass index, 22 Ϯ 1 kg/m 2 ) who were screened by a history and physical examination were studied. All subjects provided informed consent, and the study protocols were approved by the Institutional Review Board at the Penn State Milton S. Hershey Medical Center. All subjects were nonsmokers and on no medications including antioxidant vitamins or supplements. Subjects abstained from drinking caffeine for 24 h before performing the studies. All studies were performed in the General Clinical Research Center (GCRC) at Hershey, PA.
In addition, we studied four men who underwent heart transplantation 5-14 mo earlier (HTX; age 62 Ϯ 5 yr, and body mass index, 26 Ϯ 1 kg/m 2 ). The HTX patients were recruited through the transplant clinic of the Heart and Vascular Institute at the Hershey Medical Center. All transplant subjects had stable allograft function. Each of the patients was receiving a calcineurin inhibitor to prevent allograft rejection. Patients with diabetes, heart failure, renal disease, or clinical evidence of graft rejection were excluded from the study.
Measurements
Blood pressure and heart rate. Blood pressure (BP, Finapres, Ohmeda, Madison, WI) and heart rate (HR, electrocardiogram) were recorded continuously throughout the protocols. Resting BP obtained by Finapres was verified with an automated sphygmomanometer (Dinamap, Critikon, Tampa, FL).
Coronary blood velocity. CBV in the left anterior descending coronary artery (LAD) was measured with duplex ultrasound (HDI 5000, ATL Ultrasound, Bothell, WA) and was used as an index of coronary blood flow. A linear-array high-frequency transducer (7-10 MHz) with a 6-MHz pulsed-Doppler frequency was used for these studies. With the subjects in the left lateral decubitus position, the LAD was scanned along the left midclavicular line in the fourth or fifth intercostal space. The distal segment of the LAD near the cardiac apex was identified with color flow mapping, and the focal zone was then set at the depth of the LAD. The insonation angle to the artery was Յ60°. The velocity range was set at 0 -30 cm/s. The sample volume was adjusted to cover the size of the vessel. Care was taken to avoid Valsalva maneuvers during handgrip. The Doppler tracing of the diastolic portion of each cardiac cycle was analyzed using HDI 5000 ATL software to obtain mean coronary diastolic blood velocity. Because of the limited spatial resolution at the depth of the coronary arteries and the small vessel size, we did not attempt to measure coronary artery diameter. However, it has been documented that changes in CBV reliably reflect changes in absolute blood flow (13) . Beat-to-beat BP was recorded and analyzed with PowerLab Chart software (ADInstruments). The average number of data points (cardiac cycles) analyzed varied from subject to subject, and according to the duration and type of the intervention, and was 9 -13 (baseline), 11 (handgrip), 22 (LBNP), 7 (CPT), 19 (hypoxia), 23 (hyperoxia), and 14 (hypercapnia).
To validate our methodology, in six separate subjects (61 Ϯ 3 yr), we measured CBV in response to intravenous adenosine following coronary stenting by intracoronary flow wire (Flow Map 5500; Volcano, Rancho Cordova, CA) and several hours later by transthoracic Doppler. In these subjects, intravenous adenosine at 0.14 mg⅐kg Ϫ1 ⅐min
Ϫ1
, an infusion rate that induces maximal coronary vasodilation (65) , increased diastolic CBV from baseline similarly with the two different techniques (intracoronary vs. transthoracic Doppler, 62 Ϯ 10% vs. 65 Ϯ 12%, respectively; P ϭ 0.80).
Ventilatory measurements. End-tidal CO 2 (in %), minute ventilation (in l/min), and arterial O2 saturation (in %) were measured with a respiratory gas monitor and an earlobe oximeter (RGM 5250; Ohmeda).
Plasma catecholamines measurements. Venous blood samples were drawn at rest and immediately after LBNP and the CPT (see below). Plasma norepinephrine (NE) and epinephrine (EP) were analyzed by high-performance liquid chromatography (63) .
Study Protocols
Eleven subjects participated in protocols 1, 2, and 3 (day 1, see below). On a separate day, 7 out of 11 subjects returned to the GCRC to perform the ventilatory protocols (day 2, see below). All protocols were performed in a temperature-controlled room while subjects were lying on a padded table. On day 1, an intravenous catheter was placed in the antecubital vein to draw blood samples for plasma catecholamine measurements. Between the protocols, the subjects rested for 15 min. The protocol sequence on day 1 was the same in all subjects tested.
Protocol 1: static handgrip. This protocol was designed to examine the effects of short bouts of handgrip exercise on coronary hemodynamics.
First, maximal voluntary contraction (MVC) of the nondominant arm was determined in each subject with a handgrip dynamometer (Stoelting, Wood Dove, IL). Each subject received visual feedback of the amount of tension generated during handgrip.
Baseline data for HR, BP, and CBV were collected for 5 min. Each subject then completed 20-s bouts of static handgrip exercise at 10% and 70% of their respective MVC. Each bout of exercise was preceded by an ϳ1-min rest period.
Protocol 2: graded LBNP. With the subjects' lower body positioned inside a sealed LBNP chamber (up to the level of the umbilicus), the baseline HR, CBV, and BP were recorded over 5 min. Negative pressure was then applied in a graded manner beginning with Ϫ10 mmHg and increased to Ϫ30 mmHg for 3 min at each level. Blood samples were collected at baseline and at the end of LBNP. BP, HR, and CBV were recorded continuously throughout the protocol. The same sequence was maintained for all subjects. The experiment was terminated early if the subjects developed presyncopal symptoms such as lightheadedness, dizziness, nausea, diaphoresis, visual disturbances, or a sudden fall in BP.
To assess the effect of LBNP on left ventricular wall stress, an important determinant of myocardial O2 consumption and coronary blood flow, in 4 subjects, we measured the left ventricular dimensions at baseline and during LBNP (Ϫ10 mmHg) echocardiographically in the left lateral decubitus position with a 2.0 -4.0-MHz probe (46) . Left ventricular systolic and diastolic wall thickness and chamber dimensions were measured by standard M-mode technique. Mean wall stress index was calculated as systolic arterial pressure times mean radius divided by mean wall thickness, where mean radius and mean wall thickness represent the average of end-diastolic and endsystolic measurements, respectively (46) .
Protocol 3: CPT. HR, BP, and CBV were obtained for 5 min at baseline and during 90 s of immersion of one foot in iced water (CPT). Blood samples were drawn before and immediately after the procedure.
Ventilatory protocols. On day 2, a face mask with separate inlet and outlet valves was positioned and checked for leaks. The inspiratory line was connected to a reservoir bag containing the experimental gas mixture. The expiratory line was connected to the respiratory gas monitor.
After an acclimatization to the face mask for 10 min, baseline HR, BP, CBV, and ventilatory measurements were recorded for 5 min preceding each ventilatory trial while subjects were breathing room air. The subjects were then exposed for 5 min to 10% O2 in N2 (hypoxia), 100 O2 (hyperoxia), or 5% CO2 in O2 (hypercapnia) in random order with 15 min of rest between trials.
Studies in heart transplant patients. The patients with heart transplants performed the handgrip (protocol 1) and hyperoxia protocols as described above and during the same experimental session.
Data Analysis and Statistics
Beat-by-beat analysis of HR, BP, and CBV were performed for all subjects for each protocol. Average values of each variable at baseline and at each level of the different interventions were calculated and compared by repeated-measures ANOVA or paired t-test as appropriate. Bonferroni's correction was applied for post hoc testing.
Data are presented as means Ϯ SE. A P value of Ͻ0.05 was considered statistically significant.
RESULTS
Individual responses of CBV versus the pressure-rate product (systolic BP ϫ HR, an index of myocardial O 2 consumption) to the experimental interventions are shown in Fig. 1 .
Protocol 1: Responses to Static Handgrip Exercise
MVC for normal and HTX subjects was 33 Ϯ 2 and 29 Ϯ 1 kg [P ϭ not significant], respectively. In the normal subjects, significant increases in HR and BP (P Ͻ 0.001) were observed during handgrip at 70% MVC only, and CBV did not change significantly at either level (Table 1) . While the increase in BP was similar in the two groups (normal, from 78 Ϯ 6 to 91 Ϯ 5 mmHg; and HTX, from 74 Ϯ 6 to 85 Ϯ 8 mmHg), during handgrip at 70% of MVC, CBV decreased in 7 of the 10 normal subjects but increased in all 4 patients with HTX (Fig. 1A) .
Protocol 2: Responses to Graded LBNP
Although HR did not change from baseline at Ϫ10 mmHg, it increased by 12 Ϯ 7% at Ϫ30 mmHg of LBNP (P Ͻ 0.005). CBV decreased at both levels of LBNP (P Ͻ 0.02 and P Ͻ 0.01 for Ϫ10 and Ϫ30 mmHg, respectively), whereas BP did not change (Table 1, In the four subjects in whom it was determined, we found no effect of LBNP at Ϫ10 mmHg on mean wall stress index (baseline vs. LBNP Ϫ10 mmHg: 190 Ϯ 10 vs. 194 Ϯ 14 mmHg; P ϭ 0.54).
Protocol 3: Responses to CPT
HR and BP increased with CPT and was associated with a 19 Ϯ 6% increase in CBV (P Ͻ 0.01; Table 1 
Ventilatory Protocols
The data from the ventilatory protocols are shown in Tables 1  and 2 and Fig. 1, D and E.
Responses to Hypoxia
During hypoxia, O 2 saturation dropped from ϳ97 to ϳ81%, HR increased, and BP did not change. Hypoxia evoked an increase in CBV of 22 Ϯ 5% (P Ͻ 0.02; Table 1 , and Fig. 1D ).
Responses to Hyperoxia
Whereas HR decreased and BP did not change, hyperoxia decreased CBV by 15 Ϯ 3% (P Ͻ 0.01; Table 1 , and Fig. 1E ).
Responses to Hypercapnia
In one of the subjects, due to an intolerance to the hypercapnic gas mixture, the protocol was terminated early. In the Fig. 1 . Graphs show individual and mean responses of coronary blood velocity (CBV) and the pressure-rate product [systolic blood pressure ϫ heart rate (mmHg ϫ beats/min), an index of myocardial O2 consumption] to handgrip exercise (70% of maximal contraction; A), lower body negative pressure (LBNP, Ϫ30 mmHg; B), the cold pressor test (CPT; C), systemic hypoxia (D), and hyperoxia (E). Bold arrows represent mean data and open arrows represent data from the heart transplant recipients (handgrip and hyperoxia only). Note: a decrease in CBV that accompanies an increase in pressure-rate product suggests coronary vasoconstriction.
remaining six subjects, despite marked increases of minute ventilation, hypercapnia did not evoke any changes in the hemodynamic variables tested (individual data not shown).
DISCUSSION
In the present report, we examined the coronary vascular responses to physiological stress using noninvasive duplex ultrasound technology in humans. Diastolic CBV was used as a surrogate for coronary blood flow and systolic BP times HR as a correlate of myocardial O 2 consumption. The findings suggest that 1) 20-s static handgrip at high intensity evokes coronary vasoconstriction, 2) both low and moderate levels of LBNP lead to coronary vasoconstriction, 3) acute inhalation of 100% O 2 causes coronary vasoconstriction, and 4) hypoxia evokes coronary vasodilation. In the following section, these findings and their relation to prior publications are discussed.
Coronary blood flow is controlled by powerful local metabolic vasodilator mechanisms sensitive to the rate of myocardial O 2 consumption. There is also ␤-adrenoceptor-mediated coronary vasodilation and ␣-adrenoceptor-mediated coronary vasoconstriction (24, 32) . Additionally, endothelium-derived nitric oxide (NO) dilates coronary vessels secondary to augmented shear on the endothelium (56) . Although sympathetic nerves are present throughout the coronary vascular bed (9), sympathetically mediated coronary vasoconstriction predominantly occurred in the subepicardial region during static muscle contraction in anesthetized dogs (32) . Similarly, during dynamic exercise in conscious dogs, preferential subepicardial vasoconstriction maintained transmural perfusion by redistributing blood flow to the vulnerable subendocardial regions (24) . A subsequent report confirmed that coronary vasoconstriction during exercise is predominantly neurogenic in origin and serves to maintain transmural perfusion (3). However, in dynamically exercising swine, no evidence of ␣-adrenergic coronary vasoconstriction was found (14) . Whether these divergent results reflect a species effect, the type of exercise, or some other mechanism, is not clear.
In our studies, CBV did not change much during the increase in the pressure-rate product that occurred during isometric handgrip (Fig. 1A) . This is consistent with a relative vasoconstriction since an increase in pressure-rate product would be expected to produce an increase in CBV. The effect could be due to the activation of sympathetic ␣-adrenoceptors.
Although the handgrip-induced changes of CBV were small in patients with heart transplants, the fact that CBV increased in all 4 of them while it decreased in 7 of the 10 healthy volunteers despite similar increases in BP supports the notion that the CBV responses to handgrip and LBNP in normal humans may be due to sympathetically mediated coronary vasoconstriction (Fig. 1A) . It has been reported that transplanted hearts remain denervated for 12-18 mo after transplantation (4, 11, 27, 64) . Accordingly, if coronary vasoconstriction is sympathetically mediated, one would expect an attenuation of the coronary vasoconstrictor responses to physiological stress in patients with recent transplants. Although denervation supersensitivity could confound the interpretation of these 
Values are means Ϯ SE; n, number of subjects who participated in each respective trial. Percent changes (⌬%) from baseline are shown in parentheses. Responses of heart rate, mean blood pressure, and coronary blood velocity to handgrip, lower body negative pressure, cold pressor test, hypoxia, hyperoxia, and hypercapnia are shown. MVC, maximal voluntary contraction. *P Ͻ 0.05 compared to corresponding baseline values. data, because coronary sympathectomy did not elicit coronary vascular adrenergic hypersensitivity in a dog model (10), we believe it is unlikely that altered vascular sensitivity rather than sympathetic denervation in patients with heart transplants is responsible for our finding. Conversely, in three patients with heart transplant tested, the decrease in CBV in response to hyperoxia was similar to that in the healthy subjects (Fig. 1E) . This suggests that coronary vasoconstriction due to mechanisms independent of the sympathetic nervous system (SNS) is preserved in patients with heart transplants.
Of note, in all subjects, BP increased during handgrip exercise. This raises the possibility that autoregulatory mechanisms influenced the observed coronary vascular responses via increased transmural pressure and myogenic constriction (8, 29, 39) . However, when BP increased during handgrip in patients with heart transplants, CBV increased concordantly. Hence, it is unlikely that the relative coronary vasoconstriction observed in healthy subjects during handgrip exercise was due to myogenic autoregulation.
The findings reported here agree with an earlier report from our laboratory in coronary bypass graft recipients (40) where, based on blood velocity measurements in the LIMA graft to the LAD, we noted coronary vasoconstriction within 15 s of onset of high-intensity static handgrip. Whereas the present data do not reveal the precise mechanism of coronary vasoconstriction, it is plausible to speculate that it was neurally mediated based on the time course and the intensity threshold. Two important neural mechanisms are engaged to activate the SNS during exercise. One is central command, a signal emanating from higher centers of the brain that, along with the volitional component of movement, leads to parallel activation of the SNS (62) . The other mechanism, termed the exercise pressor reflex, posits that thinly myelinated muscle afferents are engaged during muscle contraction via mechanical (muscle mechanoreflex) and/or metabolic stimulation (muscle metaboreflex). Central command and the muscle mechanoreflex activate the SNS within a few seconds of the onset of muscle contraction (20, 59) , whereas the onset latency for the muscle metaboreflex is significantly longer (33, 52) . Thus the prompt onset of coronary vasoconstriction within 20 s of handgrip is likely due to central command and/or the muscle mechanoreflex. Consistent with our findings, studies in anesthetized dogs demonstrated coronary vasoconstriction within 30 s of static hindlimb contraction, which was likely due to feedback from contracting muscle and mediated by the SNS (1, 32) . Increases in cardiac sympathetic nerve activity immediately after the onset of muscle contraction were also found in anesthetized cats and suggested that the muscle mechanoreflex played an important role (35) . Whether sympathetic coronary vasoconstriction is beneficial in humans, as has been suggested in animal models (3, 24) , is not known. We speculate that in conditions associated with increased sympathetic tone, such as heart failure, hypertension, or diabetes mellitus, the magnitude of the vasoconstriction may be enhanced. However, whether in these clinical settings, coronary vasoconstriction could be precipitated by daily activities, such as gripping and holding, and could be harmful, will require future investigation.
LBNP resulted in a modest increase in the pressure-rate product and a decrease in CBV. This is good evidence for a vasoconstrictor effect, presumably via ␣-adrenoceptor activation (Fig. 1B) . The LBNP protocol was designed to determine the effects of disengagement of low-and high-pressure baroreceptors on coronary vascular tone. LBNP at Ϫ10 and Ϫ30 mmHg is known to activate the SNS by unloading low-and high-pressure baroreceptors, respectively (2, 69) . Previous studies demonstrated that LBNP led to sympathetic activation (28) as well as vasoconstriction in different vascular beds in a graded manner (41, 47) . Coronary vasoconstriction was also noted during a disengagement of baroreceptors by carotid sinus hypotension (61) or LBNP at Ϫ10 mmHg (55) . In an earlier report, Powell and Feigl (45) noted coronary vasoconstriction during carotid sinus hypotension in dogs and suggested that increased coronary vascular resistance was due to the activation of ␣-adrenergic sympathetic nerve endings. More recently, studies in healthy humans also indicated that nonhypotensive LBNP induced activation of cardiac efferent sympathetic nerves (17) . In the present report, we noted coronary vasoconstriction at both Ϫ10 and Ϫ30 mmHg without significant changes in BP. Thus it is likely that coronary vasoconstriction was due to sympathetic activation via the low-pressure (cardiopulmonary) baroreflex.
LBNP decreases cardiac preload and thereby could lower left ventricular wall stress, a primary determinant of myocardial O 2 consumption. In our study, we noted decreased CBV at both Ϫ10 and Ϫ30 mmHg of LBNP with no change in BP. To address this issue, we determined the left ventricular wall stress index by echocardiography (46) during LBNP at Ϫ10 mmHg, i.e., at a negative pressure that did not raise HR, which by itself could increase myocardial O 2 consumption. These data demonstrate no significant change in mean wall stress and therefore suggest that the decrease in CBV during LBNP was indeed due to coronary vasoconstriction, likely related to sympathetic activation.
The CPT increased the pressure-rate product with a modest increase in CBV. The vasodilation may be due to local metabolic vasodilation or activation of ␤-adrenoceptors, or a combination of both (Fig. 1C) . The CPT paradigm was designed to determine the coronary vascular responses to nonspecific sympathetic activation (51, 58 ). An enhanced reactivity of coronary arteries to CPT has been shown to predict cardiovascular events (49) . Most previous studies on coronary vascular reactivity during CPT were performed via the thermodilution technique (42), intracoronary Doppler flow wires (37, 43, 68) , or positron emission tomography (12, 37) . Consistent with reports using duplex ultrasound during 90 s of CPT in healthy humans, we noted increases in CBV that were accompanied by increases in HR, BP, and plasma catecholamines. In a classic report, Mudge et al. (42) also found no change in coronary vascular resistance in normal coronary arteries during CPT and postulated that this stimulus evoked balanced increases in sympathetic tone and vasodilator metabolites. Nabel et al. (43) suggested that ␤-adrenoceptor-, ␣ 2 -adrenoceptor-, or flowmediated mechanisms may determine coronary blood flow during CPT. However, the ␤-adrenoceptor-mediated vasodilation concept was not confirmed by Zeiher et al. (68) , who found that intracoronary administration of the nonselective ␤-adrenoceptor antagonist propranolol did not affect coronary vasodilation during CPT. Jones et al. (26) showed an enhanced ␣ 1 -adrenergic sympathetic coronary vasoconstriction after a blockade of the endothelial vasodilator nitric oxide (NO) synthase, suggesting a participation of local endothelial factors during sympathetic activation (26) . Further reports highlighted that endothelial integrity contributed significantly to the coronary vasodilator responses to CPT (37, 67) . Nevertheless, Di Carli et al. (12) provided evidence that during CPT, NE release was increased from cardiac sympathetic nerve terminals. In line with the present data, these investigators found no changes in coronary vascular resistance, although myocardial blood flow was increased during CPT. In consideration of the previous observations, it is likely that a failure of coronary vascular tone to change during CPT is the result of the opposing influences of activation of sympathetic nerves and the release of local metabolic and/or vasodilator substances.
Hypoxia resulted in a consistent increase in the pressure-rate product and CBV. The vasodilation may be due to the local effect of hypoxia on coronary vessels, or local metabolic vasodilation, or the activation of ␤-adrenoceptors or some combination of these mechanisms (Fig. 1E) . Vasodilation in the coronary vascular bed has also been observed during systemic hypoxia in animal studies (15) . Although we did not probe the precise mechanisms, prior publications shed some light onto why coronary blood flow increases during hypoxia. The classic work by Berne (5) showed that adenosine elicits coronary vasodilation in isolated cat hearts during hypoxia. Herrmann and Feigl (21) further reported that adenosinemediated coronary vasodilation during hypoxia was dependent on adrenergic activation. Recent reports suggest that besides adenosine, NO also contributes to coronary vasodilation during systemic hypoxia (34, 44) . Park et al. (44) concluded that the initial rise in coronary blood flow during hypoxia was mediated by NO, whereas in the later phase, adenosine played a role. This concept was confirmed by Ishibashi et al. (25) who noted increases in coronary blood flow in the rat heart within 1 to 2 min of systemic hypoxia before adenosine was increased. Thus, taken together, it is likely that hypoxia-induced release of adenosine as well as NO played a role in the coronary vasodilator responses seen in humans in the present report.
In anesthetized dogs, Broten et al. (6) found that reduced O 2 and increased CO 2 tension interacted synergistically to increase coronary blood flow when myocardial O 2 consumption was held constant. In addition, they observed that ϳ40% of the increase in coronary blood flow during pacing-induced increases in myocardial O 2 consumption could be explained by changes in coronary sinus O 2 and CO 2 tension. We did not measure coronary sinus O 2 or CO 2 tension. However, during the hypoxia trial in our study, decreases in arterial O 2 saturation were accompanied by decreased end-tidal CO 2 . Hence, it is possible that we would have seen even greater increases in CBV during hypoxia if we would have maintained CO 2 in the eucapnic range.
Hyperoxia resulted in a modest decrease in CBV with a modest decrease in the pressure-rate product. This may indicate a local coronary effect of hyperoxia or a change in local metabolic vasodilation. The modest decrease in CBV is probably not due to the activation of ␣-adrenoceptors because adrenergic activation would be expected to increase the pressure-rate product, which was not observed (Fig. 1E) . Recent studies suggest that high arterial O 2 tension may increase vascular tone via a generation of reactive O 2 species in the vessel wall (30) . Reactive O 2 species reduce NO availability (48, 54) and thereby oppose vasodilation. A report by McNulty et al. (36) , who studied patients with stable angina but free of flow-limiting coronary artery stenosis, supports this concept. In these studies, CBV was measured via intracoronary Doppler probe during hyperoxia before and after an administration of the antioxidant vitamin C. Vitamin C is known to improve endothelial function by scavenging free radicals and restoring NO activity (31, 53 ). An administration of vitamin C abolished the coronary vasoconstrictor responses during hyperoxia, suggesting that acute coronary vasoconstriction was a consequence of oxidative stress (36) .
In contrast to previous studies that noted coronary vasodilation during hypercapnia in animals, we did not find any effect of hypercapnia on CBV (18, 19, 57) . We cannot rule out the possibilities that differences in species or study design might explain this discrepancy.
In our studies, CBV was used as an index of coronary blood flow. To calculate absolute blood flow, a measurement of the vessel diameter is necessary. Unfortunately, the spatial resolution of ultrasound for deep-seated structures is limited and precluded a precise measurement of coronary artery diameter in the present studies. However, in previous studies, changes in CBV determined by duplex ultrasound and coronary blood flow measured with thermodilution showed an excellent correlation (22) . Indeed, we recently measured both CBV and arterial diameter during hyperoxia, employing invasive Doppler guidewire technology during coronary angioplasty in patients with stable angina (36) . Similar to the findings presented here, these studies demonstrated coronary vasoconstriction during hyperoxia without significant changes in coronary artery diameter. The decreases in CBV during hyperoxia observed in the earlier and present work were very similar (ϳ20% vs. ϳ15%). Therefore, we conclude that coronary artery diameter likely did not change during hyperoxia in our present studies and likely did not change significantly during the other experimental interventions. Moreover, since the CBV responses in the other protocols (handgrip, Ϫ5 Ϯ 6% at 70% MVC; and LBNP, Ϫ21 Ϯ 6% at Ϫ10 mmHg and Ϫ26 Ϯ 7% at Ϫ30 mmHg) were of similar magnitude, we believe it is unlikely that coronary artery diameter changed during the latter protocols. To determine the reproducibility of CBV, five subjects performed 20-s static handgrip at 70% MVC in three consecutive weeks. Handgrip-induced changes in CBV were ϩ1 Ϯ 4, ϩ7 Ϯ 4, and ϩ9 Ϯ 5%, in weeks 1, 2, and 3, respectively, and suggest good reproducibility. To further address the validity of the methodology, five subjects with LIMA grafts to the LAD were examined. In these subjects, CBV responses to static handgrip were determined simultaneously in the grafted LIMA and the LAD by two investigators using two separate ultrasound machines. As expected, similar CBV responses to static handgrip (Ϫ7 Ϯ 2% vs. Ϫ7 Ϯ 3% in LIMA and LAD, respectively; P ϭ not significant) were noted in the two different arteries. This suggests that the CBV responses assessed by duplex ultrasound in the present studies are valid.
We did not measure central venous pressure in our studies. Whereas central venous pressure does not change significantly during the CPT (16) , it may increase slightly during handgrip exercise (50) or decrease during LBNP (66) . Thus we could have slightly overestimated or underestimated coronary perfusion pressure during these interventions.
In conclusion, our findings suggest that coronary vasoconstriction occurs in healthy humans during sympathoexcitatory maneuvers, such as high-intensity static handgrip and LBNP. However, coronary vasoconstriction during hyperoxia and va-sodilation during hypoxia were also noted, suggesting the important role of mechanisms independent of the autonomic nervous system in regulating coronary vasomotor tone in humans. Collectively, our data suggest that, in healthy humans, relatively low levels of physiological stress can modulate coronary vascular tone by neural and/or direct vascular mechanisms. This may be highly relevant in cardiovascular disease where neural control as well as coronary vascular function may be altered.
